XML 23 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Commitments and Contingencies (Tables)
 6 Months Ended
Mar. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Schedule of lease payments

The Company is committed to lease payments as follows:

 

Fiscal year ending September 30,        
  2018     $ 68,463  
  2019       68,463  
        $ 136,926  
Schedule of purchase warrants outstanding

A summary of the status of the Company’s outstanding share purchase warrants is presented below:

 

            Weighted Average  
      Number of Shares     Exercise Price  
Balance, October 1, 2016       1,809,309     $ 2.70  
Exercised       (200,000 )   $ 3.00  
Balance, September 30, 2017 and March 31, 2018       1,609,309     $ 2.66  
Schedule of exercisable share purchase warrants outstanding

At March 31, 2018, the Company had share purchase warrants outstanding of 1,609,309, with a weighted average exercise price of $2.66 as follows:

 

Number   Exercise Price   Expiry Date
1,262,180   $3.00   July 5, 2018
30,000   $4.00   February 24, 2019
277,127   $1.20   March 13, 2019
1,252   $1.68   March 13, 2019
31,250   $1.24   May 31, 2019
7,500   $1.04   May 31, 2019
1,609,309        
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options is presented below:

 

                  Weighted  
            Weighted     Average  
      Number of     Average     Grant Date  
      Shares     Exercise Price     Fair Value  
Outstanding at October 1, 2016       4,199,000     $ 3.76          
Granted       1,107,500       5.51     $ 5.44  
Forfeited       (214,470 )     4.09          
Outstanding at September 30, 2017       5,092,030       4.13          
Granted       795,000       3.11     $ 2.68  
Forfeited       (6,667 )     4.20          
Exercised       (13,333 )     3.06          
Outstanding at March 31, 2018       5,867,030     $ 4.00          
Exercisable at March 31, 2018       3,782,650     $ 3.45          
Exercisable at September 30, 2017       3,326,223     $ 3.10          
Schedule of stock options outstanding

At March 31, 2018, the following stock options were outstanding: 

 

                               
Number of Shares               Aggregate     Remaining  
      Number     Exercise         Intrinsic     Contractual  
Total     Vested     Price     Expiry Date   Value     Life (yrs)  
  500,000       500,000     $ 1.60     July 5, 2023   $ 580,000       5.26  
  75,000       75,000     $ 1.20     May 7, 2024     117,000       6.10  
  125,000       93,750     $ 1.32     May 8, 2024     180,000       6.11  
  718,750       718,750     $ 0.92     April 2, 2025     1,322,500       7.01  
  29,167       29,167     $ 1.44     June 8, 2025     38,500       7.19  
  50,000       33,333     $ 1.76     June 15, 2025     50,000       7.21  
  266,250       244,063     $ 5.04     September 18, 2025     —       7.47  
  1,500       1,500     $ 5.64     September 30, 2025     —       7.50  
  31,250       26,042     $ 5.68     October 2, 2025     —       7.51  
  25,000       20,833     $ 8.98     October 16, 2025     —       7.55  
  1,500       1,500     $ 5.57     December 31, 2025     —       7.75  
  1,500       1,500     $ 4.90     March 31, 2026     —       8.00  
  1,500       1,500     $ 5.66     April 27, 2026     —       8.07  
  19,697       19,697     $ 4.09     May 18, 2026     —       8.13  
  1,500       1,500     $ 6.11     June 30, 2026     —       8.25  
  379,625       189,813     $ 6.26     July 5, 2026     —       8.26  
  861,429       430,715     $ 7.06     July 18, 2026     —       8.30  
  1,006,696       1,006,696     $ 3.28     September 22, 2026     —       8.48  
  64,166       34,166     $ 3.63     October 3, 2026     —       8.51  
  15,000       7,500     $ 4.35     December 9, 2026     —       8.69  
  50,000       16,667     $ 5.39     February 7, 2027     —       8.86  
  40,000       16,666     $ 5.26     February 17, 2027     —       8.88  
  780,000       260,000     $ 5.92     May 12, 2027     —       9.11  
  12,500       3,125     $ 3.42     August 9, 2027     —       9.36  
  15,000       3,750     $ 4.33     September 19, 2027     —       9.47  
  545,000       45,417     $ 3.30     December 13, 2027     —       9.70  
  50,000       —     $ 2.60     March 2, 2028     8,000       9.92  
  200,000       —     $ 2.72     March 19, 2028     8,000       9.97  
  5,867,030       3,782,650                 $ 2,304,000          
Schedule of general and administrative expenses and research and development expenses

These amounts have been included in general and administrative expenses and research and development expenses on the Company’s statement of operations as follows:

  

    Three months ended March 31,     Six months ended March 31,  
    2018     2017     2018     2017  
General and administrative   $ 625,679     $ 450,128     $ 1,197,041     $ 877,711  
Research and development     600,017       518,765       1,150,640       980,449  
Total share based compensation   $ 1,225,696     $ 968,893     $ 2,347,681     $ 1,858,160  
Schedule of weighted average assumptions for fair value of each option award

The fair value of each option award is estimated on the date of grant using the Black Scholes option pricing model based on the following weighted average assumptions:

 

    2018     2017  
Risk-free interest rate     2.43 %     1.76 %
Expected life of options (years)     6.57       6.79  
Annualized volatility     112.23 %     111.81 %
Dividend rate     0.00 %     0.00 %